COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02052388
Recruitment Status : Completed
First Posted : February 3, 2014
Last Update Posted : September 26, 2018
Information provided by (Responsible Party):
Innovation Pharmaceuticals, Inc. ( Cellceutix Corporation )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2014
Actual Study Completion Date : October 2014